Actively Recruiting
Prospective Cohort Study of Intracerebral Hemorrhage
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2021-03-18
856
Participants Needed
1
Research Sites
309 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators design a prospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective ,treatments and prognosis of Chinese hospitalised adult patients with intracerebral hemorrhage.
CONDITIONS
Official Title
Prospective Cohort Study of Intracerebral Hemorrhage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospitalized patients over 18 years old with primary intracerebral hemorrhage
You will not qualify if you...
- Patients with secondary intracerebral hemorrhage such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arteriovenous malformations, central venous thrombosis, trauma-related, or tumor causes
- Patients with isolated intraventricular hemorrhage or subarachnoid hemorrhage
- Pregnant patients
- Patients who have had surgical evacuation of hematoma
- Patients unable to provide complete blood cell samples or who have contraindications or refuse MRI
- Patients who cannot be followed up for any reason
- Patients who die within 24 hours
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
2nd Affiliated Hospital, School of Medicine at Zhejiang University
Hangzhou, Zhejiang, China, 310000
Actively Recruiting
Research Team
F
Feng Gao, MD,PhD
CONTACT
L
Lusha Tong, MD,PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here